Pharmaceutical Executive
May 06, 2016
Features
36
4
European pharma is bracing itself for EFPIA’s June deadline requiring the disclosure of transfer-of-value transactions make to HCPs. Pharm Exec looks at how the industry is preparing for this historic moment.
April 28, 2016
Column
36
4
Limitations of the Drug Supply Chain Security Act for pharma-and three strategies to fix them.
April 27, 2016
Features
36
4
Charting two years of collaborative progress in clinical trial data sharing.
April 15, 2016
Features
36
4
Pharm Exec profiles Roche’s Jennifer Cook, this year’s winner of the Healthcare Businesswomen’s Association Woman of the Year award, who has built a career in close parallel to the rise of biotech as a mainstream and integral driver of global health innovation.
April 12, 2016
Column
36
4
The importance of betting on outcomes, not simply risk sharing, when implementing pharma-payer arrangements. .
April 11, 2016
Column
36
4
Why the industry needs more women in senior management roles-and the three strategies to get there.
April 01, 2016
Features
36
4
How the DIA, a key industry NGO, is repositioning itself as the go-to place for the independent knowledge-driven insights that drive decisions in a business with no boundaries. One world. One table. Open seating.
April 01, 2016
Column
36
4
Altruism and self-interest are at the heart of European thinking on neglected diseases.
April 01, 2016
Column
36
4
The courts, pharma, and policymakers push FDA to rethink communications policy.
April 01, 2016
Column
36
4
The practice’s emerging-if improbable-cost-saving potential.
April 01, 2016
From the Editor
36
4
The challenges facing the ad industry and big Pharma are remarkably similar-a point driven home by four distinct themes at this year's 4A's Transformation conference illustrate.
April 01, 2016
Special Sponsored Section
36
4
Egypt is not just a sun-soaked paradise defined by pyramids and tombs, or-alternatively-a hotbed for political turmoil and revolution. It’s also a vibrant and growing market for pharmaceuticals, experts contend.
April 01, 2016
Issue PDF
36
4
Click the title above to open the Pharmaceutical Executive April 2016 issue in an interactive PDF format.